The role of pelvic lymph node dissection (PLND) in patients with localized prostate cancer remains controversial. Although guidelines are increasingly recommending extended PLND alongside radical ...

We prospectively assessed 61 pelvic lymph node dissection specimens (packets) in 14 consecutive patients undergoing radical cystectomy. The final pathologic stage of the tumors present in the ...

The gold standard for management of MIBC has been radical removal of the bladder with concomitant pelvic lymph node dissection (LND) -- i.e., radical cystectomy.

Lymph node dissection conducted during radical cystectomy is essential for tumor staging in patients with invasive bladder cancer. It might also provide therapeutic benefits for these patients and ...

Background: The therapeutic benefit of pelvic lymph node dissection (PLND) in the surgical treatment of localized prostate cancer remains unproven. In this trial we aim to evaluate whether PLND ...

Pelvic lymph node dissection still may be required in men with intermediate- or high-risk prostate cancer who have a negative finding on a 68 Ga-PSMA-11 PET scan, according to a recent study. A ...

But no patients in the biopsy-only group had a recurrence in the retroperitoneal lymph nodes compared with 9 patients in the pelvic lymphadenectomy group. The 3-year disease-free survival (primary ...

The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: A systematic review. Eur Urol. 2017;72:84-109.

For the 40% of patients with muscle-invasive bladder cancer (MIBC) who have micrometastatic nodal occult disease, current management includes either with pelvic lymph node dissection (PLND) or ...

Patients with muscle invasive (P2 and P3a), lymph node–negative tumors had 89% and 87% and 78% and 76% 5- and 10-year recurrence-free survival, respectively. Patients with nonorgan-confined (P3b, P4), ...